Apathy in patients with Alzheimer's disease is a cost-driving factor.
Christopher KruseFranziska MaierAnnika SpottkeJan-Philipp BachClaudia BartelsKatharina BuergerAndreas FellgiebelKlaus FliessbachLutz FrölichLucrezia HausnerMartin HellmichStefan KlöppelArne KlostermannJohannes KornhuberChristoph LaskeOliver PetersJosef PrillerTanja Richter-SchmidingerAnja SchneiderKija Shah-HosseiniStefan TeipelChristine A F von ArnimJens WiltfangHendrik van der WurpRichard DodelFrank JessenPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2023)
Apathy is a significant cost driving factor for total costs in mild to moderate DAT. Effective treatment of apathy might be associated with reduced overall costs in DAT.
Keyphrases